RAD Rite Aid Corp. featured news, full reports, and detailed charts
Rite Aid Corp. (RAD) Wrap Up:
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores. Its retail stores primarily provide pharmacy services. The company sells prescription drugs and a range of front-end products. Rite Aid Corporation offers approximately 26,300 front-end products, which include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, beverages, convenience foods, greeting cards, seasonal merchandise, and various other everyday and convenience products, as well as photo processing. It offers its products under the Rite Aid private brand. It serves customers covered by health plan contracts, which contract with third parties payor...Rite Aid Corp. (RAD:NYSE)
Snapshot of Rite Aid Corp. (RAD)
|
OPEN
$1.32
|
PREVIOUS CLOSE
$1.34
|
||
|
DAY HIGH
$1.34
|
DAY LOW
$1.28
|
||
|
52 WEEK HIGH
09/17/09 - $2.35
|
52 WEEK LOW
03/6/09 - $0.20
|
||
|
MARKET CAP
1.1B
|
AVERAGE VOLUME 3 mo
6.6M
|
||
|
DILUTED EPS TTM
$-3.22
|
SHARES OUTSTANDING
888.1M
|
||
|
RAD Does Not Pay Dividends
|
P/E TTM
NM
|
||
| K = Thousands M = Millions B = Billions | |||
| > | |||
related news
With junk bonds no longer cheap, how you assess high-yield risk becomes more important. Should you treat them like stocks?
With junk bonds no longer cheap, how you assess high-yield risk becomes more important. Should you treat them like stocks?
Wal-Mart has fallen behind on plans for putting retail medical clinics in its stores, but says it hasn't given up on this growth area
Employee screening has become a big business, but not always an accurate one
related news
RAD Top Compensated Officers
Executives, Board Directors
Key developments for Rite Aid Corp. (RAD)
Rite Aid Corp. - Conference Presentation Calls
Rite Aid Corp. announced sales results for October. For the four weeks ended October 24, 2009, same store sales decreased 0.5% over the prior-year period. Front-end same store sales decreased 2.7% while pharmacy same store sales, which included an approximate 200 basis points negative impact from new generic introductions, increased 0.5%. Prescriptions filled at comparable stores increased 1.8% over the prior-year period. Total drugstore sales for the four-week period decreased 1.7% to $1.962 billion compared to $1.997 billion for the same period last year. Prescription revenue accounted for 69.0% of drugstore sales, and third party prescription revenue represented 96.2% of pharmacy sales. Same store sales for the 34-week period ended October 24, 2009 decreased 0.3%consisting of a 3.1% front-end same store sales decrease and a 1.1% increase in pharmacy same store sales. Total drugstore sales for the 34 weeks decreased 1.9% to $16.706 billion from $17.027 billion in last year's like period. Prescription revenue accounted for 68.3% of total drugstore sales, and third-party prescription revenue was 96.3% of pharmacy sales.
Rite Aid Corp. announced the terms of an offering of $270 million aggregate principal amount ($20 million more than previously announced) of 10.250% senior secured notes due 2019 (with a yield to maturity of 10.375%, based on an offering price of 99.242% per note). The notes will be unsecured, unsubordinated obligations of Rite Aid Corporation and will be guaranteed by substantially all of Rite Aid's subsidiaries. The guarantees will be secured on a second lien basis. The transaction is expected to close on October 26, 2009, subject to customary closing conditions. The offering of the notes is part of Rite Aid's previously announced comprehensive plan to refinance its existing first lien accounts receivable securitization facility and second lien accounts receivable securitization facility due September 2010. As of October 16, 2009, there was $475 million outstanding under the securitization facilities. Rite Aid has also received commitments to increase the borrowing capacity under Rite Aid's existing senior secured revolving credit facility from $1.0 billion to $1.175 billion. Also included in the refinancing plan is an increase in borrowing under Rite Aid's existing $525 million senior secured term loan due June 2015 by $125 million to $650 million.
RAD Competitors
| Company | Last | Change |
| Aetna Inc | $28.40 USD | -0.29 |
| CIGNA Corp | $30.03 USD | +0.19 |
| Express Scripts Inc | $85.09 USD | +1.05 |
| Humana Inc | $40.44 USD | -0.39 |
| SUPERVALU Inc | $14.94 USD | -0.19 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | RAD | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.0x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
|
RAD |
||
RAD transactions
| Type Date |
Target |
|
Private Placement
October 19, 2009 |
-- |
|
Private Placement
June 8, 2009 |
-- |
